GSK plc is a global healthcare company that focuses on the research, development, and manufacture of vaccines and medicines. Its primary customers include healthcare providers, governments, and patients in the United Kingdom, the United States, and other international markets. Revenue is generated through two main segments: Commercial Operations, which includes vaccine sales (approximately 50%) and specialty/general medicines (approximately 40%), and Total R&D (approximately 10%). Factors supporting GSK's endurance include a strong pipeline of innovative products and a long history in the pharmaceutical industry. However, challenges such as regulatory hurdles and competition from generic drugs could limit its growth potential.
—
GSK plc is a global healthcare company that focuses on the research, development, and manufacture of vaccines and medicines. Its primary customers include healthcare providers, governments, and patients in the United Kingdom, the United States, and other international markets. Revenue is generated through two main segments: Commercial Operations, which includes vaccine sales (approximately 50%) and specialty/general medicines (approximately 40%), and Total R&D (approximately 10%). Factors supporting GSK's endurance include a strong pipeline of innovative products and a long history in the pharmaceutical industry. However, challenges such as regulatory hurdles and competition from generic drugs could limit its growth potential.
—
Daily adjusted close
GSK plc is a global healthcare company that focuses on the research, development, and manufacture of vaccines and medicines. Its primary customers include healthcare providers, governments, and patients in the United Kingdom, the United States, and other international markets. Revenue is generated through two main segments: Commercial Operations, which includes vaccine sales (approximately 50%) and specialty/general medicines (approximately 40%), and Total R&D (approximately 10%). Factors supporting GSK's endurance include a strong pipeline of innovative products and a long history in the pharmaceutical industry. However, challenges such as regulatory hurdles and competition from generic drugs could limit its growth potential.